Lower ARV price to benefit S Africa, increase recipient numbers
A new antiretroviral (ARV) pricing agreement reached by the South African government, international organisations and agencies will ensure that more people will have access to treatment, while saving South Africa nearly R12-billion over the next six years.
A statement released by the Department of Health on Friday revealed that the single-pill HIV treatment regimen containing dolutegravir (DTG) will be available to low and middle-income countries at a price of $75 per person, a year.
Minister of Health Aaron Motsoaledi said that the large volumes of ARVs purchased by South Africa were used to leverage the decrease in pricing.
“The agreement is expected to accelerate treatment roll-out as part of global efforts to reach all 36.7-million people living with HIV with high-quality antiretroviral therapy. South Africa will introduce the new fixed dose combination of three drugs, Tenofovir, Lamivudine and TLD in April 2018,” said Motsoaledi.
Dolutegravir is an extremely effective antiretroviral with fewer side effects. Patients are, therefore, more likely to be adherent and more likely to be virally suppressed – which means that they are not likely to transmit the virus to others.
Parties involved in the pricing agreement included South Africa together with Kenya, in partnership with the Clinton Health Access Initiative, the Joint United Nations Programme on HIV/Aids, the Bill & Melinda Gates Foundation, UNITAID, the UK’s Department for International Development, the US President’s Emergency Plan for AIDS Relief, the US Agency for International Development, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
“The considerable price reductions could yield savings of up to R11.7-billion over the next six years for us, which means that we can initiate additional patients on treatment with the same amount of resources. Ramping up treatment with good viral suppression will enable us to reach HIV epidemic control more quickly,” said Motsoaledi.
Comments
Press Office
Announcements
What's On
Subscribe to improve your user experience...
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation